Molnupiravir: China grants conditional approval for COVID treatment
China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical… Read More
2 years ago
molnupiravir
WHO recommends Merck’s COVID pill for high-risk patients
A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck &… Read More
3 years ago
Merck’s COVID-19 pill effective against Omicron in lab studies
Merck and partner Ridgeback Biotherapeutics said on Friday six lab studies showed that their experimental… Read More
3 years ago
UK to begin testing Merck’s COVID pill for hospitalised patients
UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible… Read More
3 years ago
Mexico grants emergency use approval for Merck’s COVID-19 pill
Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's COVID-19 pill Molnupiravir,… Read More
3 years ago
Belgium to buy 10,000 courses each of Pfizer and Merck COVID-19 pills
Belgium will buy 10,000 courses each of the COVID-19 pills developed by Pfizer and Merck,… Read More
3 years ago
Japan health panel approves Merck’s oral COVID-19 treatment
A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed… Read More
3 years ago
France cancels order for Merck’s COVID-19 antiviral drug
France has cancelled its order for Merck's COVID-19 antiviral drug following disappointing trial data and… Read More
3 years ago
Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted
Indonesia is reviewing a COVID-19 experimental antiviral pill- molnupiravir- produced by Merck for domestic use,… Read More
3 years ago
Britain approves Merck’s COVID-19 pill in world first
Britain on Thursday became the first country in the world to approve a potentially game-changing… Read More
3 years ago
Molnupiravir: Countries rush to buy Merck experimental COVID-19 pill
Merck has signed eight deals to sell more than a total of 2 million courses… Read More
3 years ago
Merck signs pact to allow more companies to manufacture COVID-19 pill
Merck has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that… Read More
3 years ago
Molnupiravir: Heres’ what you need to know about Merck’s COVID-19 pill
As Merck and partner Ridgeback Biotherapeutics announced earlier this month that their pill Molnupiravir was… Read More
3 years ago
WHO says it awaits full data from Merck on COVID-19 pill molnupiravir
The World Health Organization is awaiting full clinical data on the antiviral pill made by… Read More
3 years ago
Merck applies for US authorization of COVID-19 pill
Merck & Co said on Monday it has applied for emergency use authorization in the… Read More
3 years ago
Merck and Singapore sign deal on COVID-19 antiviral pill
Pharmaceutical company Merck announced on Wednesday a supply and purchase agreement with Singapore that will… Read More
3 years ago
Merck’s COVID-19 pill cuts risk of death, hospitalization by 50%: study
Merck's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization… Read More
3 years ago
United States signs $1.2 bln deal for ‘COVID-19 drug’
The oral antiviral treatment, molnupiravir, aims to stop COVID-19 from progressing and can be given… Read More
3 years ago